By using our website, you agree to the use of our cookies.

News

Monthly summary – March 2024

By Karin April 5, 2024

What a difference a year makes! Even though stock markets performed well during the first quarter of 2023, the beginning of 2024 has been characterized by a much more ebullient mood. The dark scenarios that dominated investment banks’ strategies in early 2023 did not materialize and investors’ appetite for risk successively increased throughout the year, […]

Rhenman & Partners strengthens its investor relations team

By Karin March 26, 2024

Rhenman & Partners hires Tom Josephson as Investor Relations Director. Tom, together with Erica von Bahr (also part of the Investor Relations team), will work with investors in Sweden and internationally. Tom’s main focus will however be on Nordic investors. Tom joins Rhenman & Partners from Brummer & Partners, where he spent nearly 18 years […]

Monthly summary – February 2024

By Karin March 6, 2024

The positive momentum persisted into February, traditionally a challenging month for markets. Contrary to expectations, stock prices increased despite rising bond yields, catching many investors by surprise. Again, the US mega caps dominated trading and performance attribution with, for example, chipmaker Nvidia rallying after a stellar report to become the third company ever to reach […]

Monthly summary – January 2024

By Karin February 7, 2024

Happy New Year! January turned out to be the third consecutive month with positive stock market returns overall despite investors’ initial hesitation. After the very strong finish in 2023, with November and December delivering bumper price increases, the new year however started off on a more apprehensive note. This was due not least to the […]

Monthly summary – December 2023

By Karin January 11, 2024

What a difference a couple of months makes! After a dismal period in August through October, markets swung around completely in November and December as investor sentiment turned for the better. Following November, when positive market action was largely due to short covering, price movements in December reflected a generally increased risk willingness on behalf […]

Monthly summary – November 2023

By Karin December 6, 2023

The end of the rate hiking cycle and rallies in both equities and bonds! After three dismal months where investors fretted about rising bond yields, uncertainty over inflation and/or recession, and the geopolitical situation, sentiment positioning was at a year low at the end of October. In November, however, all these concerns seemed to dissipate […]

Monthly summary – October

By Karin November 7, 2023

Rising bond yields, recession fears and war! Following a dismal performance in August and September, equity markets continued down in October with a third consecutive month of falling prices. On top of the worries of “higher for longer” bond yields and the implicit risk for the overall economy going forward, the Hamas terrorist attack against […]

The complex reality of investing in Biopharma

By Karin October 12, 2023

There has been a lot of buzz recently about the new treatment methods for Alzheimer’s disease and obesity. These breakthroughs are encouraging for patients and their families and bring hope of a better quality of life. Beneath the surface of these positive readouts, we see an ever-growing number of clinical trials in various therapeutic areas […]

Monthly summary – September

By Karin October 4, 2023

Rising rates and recession fears. The seasonal pattern of a weak late summer and early autumn came true once again, and equity markets sold off in September. In the absence of earnings reports and other major corporate news, investors focused solely on macroeconomic developments, especially in the US. Interest was centered on several issues: Fast […]

Visa fler nyheter